DIFFERENTIAL REGULATION OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVITY IN PATIENTS WITH DIFFERING ETIOLOGIES OF HYPOPITUITARISM

作者: Amar Agha , Lucy Ann Behan , Hannah Forde , Norman F. Taylor , Diarmuid Smith

DOI: 10.4158/EP-2018-0154

关键词: Cushing Disease11β-hydroxysteroid dehydrogenase type 1CortisoneHydrocortisoneTetrahydrocortisoneHypopituitarismTetrahydrocortisolMedicineEndocrinologyHormoneInternal medicine

摘要: ABSTRACT Objective: Pituitary patients with different etiologies of hypopituitarism exhibit differing phenotypes, despite similar replacement therapy strategies. We hypothesized that differential regulation the isoenzyme 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1), which mediates net autocrine conversion cortisone to cortisol in adipose tissues and liver, may play a role. Methods: studied 11β-HSD1 activity (using urine cortisol/cortisone metabolites ratio) 36 hypopituitary treated craniopharyngiomas, remitted Cushing disease, nonfunctioning pituitary adenomas + prolactinomas on off growth hormone (GH) replacement. Results: was higher subjects craniopharyngioma both GH, as evidenced by increased tetrahydrocortisol tetrahydrocortisone metabolite ratios compared other diagnostic groups, but there no difference body mass index, insulin levels, serum measurements, or hydrocortisone dose between gro...

参考文章(20)
Nicholas M. Morton, Jonathan R. Seckl, 11beta-hydroxysteroid dehydrogenase type 1 and obesity. Frontiers of Hormone Research. ,vol. 36, pp. 146- 164 ,(2008) , 10.1159/000115363
Lucy‐Ann Behan, Bairbre Rogers, Mark J. Hannon, Patrick O’Kelly, William Tormey, Diarmuid Smith, Christopher J. Thompson, Amar Agha, Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients Clinical Endocrinology. ,vol. 75, pp. 505- 513 ,(2011) , 10.1111/J.1365-2265.2011.04074.X
E. Profka, C. Giavoli, S. Bergamaschi, E. Ferrante, E. Malchiodi, E. Sala, E. Verrua, G. Rodari, M. Filopanti, P. Beck-Peccoz, A. Spada, Analysis of short- and long-term metabolic effects of growth hormone replacement therapy in adult patients with craniopharyngioma and non-functioning pituitary adenoma. Journal of Endocrinological Investigation. ,vol. 38, pp. 413- 420 ,(2015) , 10.1007/S40618-014-0196-0
Søren Kildeberg Paulsen, Steen Bønløkke Pedersen, Jens Otto Lunde Jørgensen, Sanne Fisker, Jens Sandahl Christiansen, Allan Flyvbjerg, Bjørn Richelsen, None, Growth Hormone (GH) Substitution in GH-Deficient Patients Inhibits 11β-Hydroxysteroid Dehydrogenase Type 1 Messenger Ribonucleic Acid Expression in Adipose Tissue The Journal of Clinical Endocrinology and Metabolism. ,vol. 91, pp. 1093- 1098 ,(2006) , 10.1210/JC.2005-1694
E H Rabbitt, J Ayuk, K Boelaert, M C Sheppard, M Hewison, P M Stewart, N J L Gittoes, Abnormal expression of 11 beta-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation. Oncogene. ,vol. 22, pp. 1663- 1667 ,(2003) , 10.1038/SJ.ONC.1206293
Jolanta U. Weaver, Lakshmi Theventhiran, Kate Noonan, Jacqueline M. Burrin, Norman F. Taylor, Michael R. Norman, John P. Monson, The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clinical Endocrinology. ,vol. 41, pp. 639- 648 ,(1994) , 10.1111/J.1365-2265.1994.TB01830.X
F. M. Swords, P. V. Carroll, J. Kisalu, P. J. Wood, N. F. Taylor, J. P. Monson, The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement Clinical Endocrinology. ,vol. 59, pp. 613- 620 ,(2003) , 10.1046/J.1365-2265.2003.01894.X
María-José Barahona, Nuria Sucunza, Eugenia Resmini, José-Manuel Fernández-Real, Wifredo Ricart, José-María Moreno-Navarrete, Teresa Puig, Jordi Farrerons, Susan M. Webb, Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism. ,vol. 94, pp. 3365- 3371 ,(2009) , 10.1210/JC.2009-0766
Amar Agha, John P. Monson, Modulation of glucocorticoid metabolism by the growth hormone - IGF-1 axis. Clinical Endocrinology. ,vol. 66, pp. 459- 465 ,(2007) , 10.1111/J.1365-2265.2007.02763.X
J. S. Moore, J. P. Monson, G. Kaltsas, P. Putignano, P. J. Wood, M. C. Sheppard, G. M. Besser, N. F. Taylor, P. M. Stewart, Modulation of 11β-Hydroxysteroid Dehydrogenase Isozymes by Growth Hormone and Insulin-Like Growth Factor: In Vivo and In Vitro Studies1 The Journal of Clinical Endocrinology and Metabolism. ,vol. 84, pp. 4172- 4177 ,(1999) , 10.1210/JCEM.84.11.6108